JP2008512378A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512378A5
JP2008512378A5 JP2007530397A JP2007530397A JP2008512378A5 JP 2008512378 A5 JP2008512378 A5 JP 2008512378A5 JP 2007530397 A JP2007530397 A JP 2007530397A JP 2007530397 A JP2007530397 A JP 2007530397A JP 2008512378 A5 JP2008512378 A5 JP 2008512378A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
nhc
disease
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530397A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512378A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/031317 external-priority patent/WO2006028963A2/en
Publication of JP2008512378A publication Critical patent/JP2008512378A/ja
Publication of JP2008512378A5 publication Critical patent/JP2008512378A5/ja
Pending legal-status Critical Current

Links

JP2007530397A 2004-09-03 2005-08-31 置換複素環式化合物及びその使用 Pending JP2008512378A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60740804P 2004-09-03 2004-09-03
PCT/US2005/031317 WO2006028963A2 (en) 2004-09-03 2005-08-31 Substituted heterocyclic compounds and uses thereof

Publications (2)

Publication Number Publication Date
JP2008512378A JP2008512378A (ja) 2008-04-24
JP2008512378A5 true JP2008512378A5 (cg-RX-API-DMAC7.html) 2008-10-30

Family

ID=35462424

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530397A Pending JP2008512378A (ja) 2004-09-03 2005-08-31 置換複素環式化合物及びその使用

Country Status (12)

Country Link
US (2) US7468446B2 (cg-RX-API-DMAC7.html)
EP (1) EP1794139A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008512378A (cg-RX-API-DMAC7.html)
KR (1) KR20070050987A (cg-RX-API-DMAC7.html)
CN (1) CN101052630A (cg-RX-API-DMAC7.html)
AR (1) AR050557A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005282727A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514857A (cg-RX-API-DMAC7.html)
CA (1) CA2578789A1 (cg-RX-API-DMAC7.html)
IL (1) IL181677A0 (cg-RX-API-DMAC7.html)
WO (1) WO2006028963A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200702380B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006028963A2 (en) * 2004-09-03 2006-03-16 Celgene Corporation Substituted heterocyclic compounds and uses thereof
JP2009539774A (ja) * 2006-06-03 2009-11-19 サイリーン ファーマシューティカルズ インコーポレーティッド 薬物の投与方法
CN100586932C (zh) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 抗肿瘤化合物及其制备方法
GEP20125574B (en) * 2008-01-11 2012-07-10 Glenmark Pharmaceuticals Sa Fused pyrimidine derivatives as trpv3 modulators
US8119647B2 (en) * 2008-04-23 2012-02-21 Glenmark Pharmaceuticals S.A. Fused pyrimidineone compounds as TRPV3 modulators
CA2790407A1 (en) * 2010-03-11 2011-09-15 Oxigene, Inc. Ophthalmic formulations
DE202011108135U1 (de) 2011-11-11 2012-02-06 Metso Paper, Inc. Vorrichtung zur Entlüftung eines auf eine Faserbahn aufzutragenden Beschichtungsmedium
EP2961746B1 (en) 2013-02-28 2018-01-03 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
SMT202100509T1 (it) * 2013-04-17 2021-11-12 Sage Therapeutics Inc Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia
CN105764904B (zh) 2013-09-12 2020-02-11 詹森生物制药有限公司 氮杂-吡啶酮化合物及其用途
WO2016145103A1 (en) 2015-03-11 2016-09-15 Alios Biopharma, Inc. Aza-pyridone compounds and uses thereof
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
CN107149005B (zh) * 2017-04-18 2021-05-04 安徽农业大学 一种红茶菌戊聚糖奶片的制备方法
CN109851601A (zh) * 2019-03-29 2019-06-07 吉首大学 一种含氰基苯并呋喃的合成方法和用途
CN115286562B (zh) * 2022-08-18 2024-02-23 青海大学 含有富电子的芳杂环或芳胺类化合物的苯甲酰化方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE208999C (cg-RX-API-DMAC7.html)
US3094533A (en) * 1961-10-13 1963-06-18 Pfizer & Co C 3-pyridyl-acrylonitriles
US4420479A (en) 1982-04-08 1983-12-13 Eli Lilly And Company Olefinic benzimidazoles, formulations, and antiviral methods
US4492708A (en) 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
JPS58188868A (ja) 1983-04-08 1983-11-04 イ−ライ・リリ−・アンド・カンパニ− オレフイン系ベンズイミダゾ−ル類
DE3525623A1 (de) * 1985-07-18 1987-01-22 Celamerck Gmbh & Co Kg Fungizid wirksame acrylsaeureamide
JPH0830063B2 (ja) * 1986-11-18 1996-03-27 富山化学工業株式会社 新規なイミダゾ−ル誘導体およびその塩
ATE95176T1 (de) 1987-10-21 1993-10-15 Du Pont Merck Pharma Aminomethyl-oxo-oxazolidinyl-ethenylbenzenderivate, nuetzlich als antibakterielles mittel.
US5006435A (en) * 1988-10-05 1991-04-09 Fuji Xerox Co., Ltd. Electrophotographic photosensitive member with additive in charge generating layer
JPH0566591A (ja) 1991-09-10 1993-03-19 Canon Inc 電子写真感光体、該電子写真感光体を備えた電子写真装置並びにフアクシミリ
DE4220983A1 (de) 1992-06-26 1994-01-05 Bayer Ag Imidazolyl-substituierte Phenylpropion- und -zimtsäurederivate
EP0665224A1 (en) * 1992-10-16 1995-08-02 Nippon Soda Co., Ltd. Pyrimidine derivative
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US6429221B1 (en) * 1994-12-30 2002-08-06 Celgene Corporation Substituted imides
US5728844A (en) * 1995-08-29 1998-03-17 Celgene Corporation Immunotherapeutic agents
US5728845A (en) * 1995-08-29 1998-03-17 Celgene Corporation Immunotherapeutic nitriles
FI990180A7 (fi) 1996-08-12 1999-03-08 Celgene Corp Uusia immunoterapeuttisia aineita ja niiden käyttö sytokiini-tasojen pienentämiseksi
AU4849199A (en) 1998-07-01 2000-01-24 Celgro Fungal growth inhibitors
US6667316B1 (en) * 1999-11-12 2003-12-23 Celgene Corporation Pharmaceutically active isoindoline derivatives
MY129677A (en) * 2000-09-20 2007-04-30 Schering Corp Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
KR20050090435A (ko) * 2002-12-30 2005-09-13 셀진 코포레이션 플루오로알콕시-치환된 1,3-디히드로-이소인돌릴 화합물 및그의 제약학적 용도
WO2006028963A2 (en) * 2004-09-03 2006-03-16 Celgene Corporation Substituted heterocyclic compounds and uses thereof

Similar Documents

Publication Publication Date Title
US8765741B2 (en) 5,6-dihydro-1H-pyridin-2-one compounds
CA2656000C (en) Pyrro[1,2-b]pyridazinone compounds
CA2671982A1 (en) Methods of using mek inhibitors
JP2008512374A5 (cg-RX-API-DMAC7.html)
AR040803A1 (es) Ligandos de receptores canabinoides, composiciones farmaceuticas, un proceso para su elaboracion y el uso de dichos compuestos, solos o combinados, para la preparacion de medicamentos
WO2006066079A2 (en) Pyridazinone compounds
RU99112569A (ru) Бициклические арильные карбоксамиды и их терапевтическое применение
US8735434B2 (en) Compounds as cannabinoid receptor ligands
WO2008144500A2 (en) 1-methyl-benzo[1,2,4]thiadiazine, 1-oxide derivatives
JP2019501927A5 (cg-RX-API-DMAC7.html)
PT1406899E (pt) Derivados de fenilacetamido-tiazole, processo para a sua preparação e a sua utilização como agentes antitumorais
JP2007063257A (ja) 新規縮合ヘテロサイクル及びその使用
US20090062263A1 (en) 4-Hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
JP2007503432A5 (cg-RX-API-DMAC7.html)
US20080275032A1 (en) Pyridazinone compounds
US8222404B2 (en) [1,2,4]Thiadiazin-3-yl acetic acid compound and methods of making the acetic acid compound
ES2578363B1 (es) Moduladores de los receptores A3 de adenosina
US20080227774A1 (en) 5,5-disubstituted-indolizinone compounds
CN100372855C (zh) 具有抗肿瘤活性的喜树碱的7-亚氨基衍生物
US8129368B2 (en) 5,6-dihydro-1H-pyridin-2-one compounds
WO1982001551A1 (en) Beta-lactamase-inhibiting composition
CA3236134A1 (en) Imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4
HK1130781B (en) Pyrro [1,2-b] pyridazinone compounds